# First Wave BioPharma Inc. (FWBI)

Source: https://www.quantisnow.com/company/FWBI
Generated: 2026-11-19T21:28:22.925Z

- Ticker: FWBI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2016

## Latest FWBI news and filings

- 2024-05-16 11:30 UTC [Market Chatter] [First Wave BioPharma Changes Name to Entero Therapeutics, Company Advances Toward Phase 3 Clinical Trial With Lead Asset – Latiglutenase For The Treatment Of Celiac Disease](https://www.quantisnow.com/insight/first-wave-biopharma-changes-name-to-entero-therapeutics-company-advances-5495404)
- 2024-05-16 11:16 UTC [SEC Form 8-K] [First Wave BioPharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/first-wave-biopharma-inc-filed-sec-form-8-k-amendments-to-5495340)
- 2024-05-16 11:00 UTC [First Wave BioPharma Changes Name to Entero Therapeutics](https://www.quantisnow.com/insight/first-wave-biopharma-changes-name-to-entero-therapeutics-5495278)
- 2024-05-14 21:26 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by First Wave BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-first-wave-biopharma-inc-5490347)
- 2024-05-13 21:26 UTC [SEC Form 8-K] [First Wave BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/first-wave-biopharma-inc-filed-sec-form-8-k-entry-into-5486327)
- 2024-05-13 20:59 UTC [SEC Form 424B5] [SEC Form 424B5 filed by First Wave BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-first-wave-biopharma-inc-5486091)
- 2024-05-10 12:00 UTC [Market Chatter] [First Wave BioPharma Announces ~$1.1M Registered Direct Offering Of 366,000 Shares Of Common Stock At A Price Of $2.95/Share, Priced At The Market](https://www.quantisnow.com/insight/first-wave-biopharma-announces-11m-registered-direct-offering-of-366000-5480178)
- 2024-05-10 11:55 UTC [Public Offering] [First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market](https://www.quantisnow.com/insight/first-wave-biopharma-inc-to-raise-approximately-11-million-of-5480136)
- 2024-05-09 11:00 UTC [First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month](https://www.quantisnow.com/insight/first-wave-biopharma-and-celiac-journey-to-host-nasdaq-event-5474756)
- 2024-05-08 21:16 UTC [SEC Form 8-K] [First Wave BioPharma Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/first-wave-biopharma-inc-filed-sec-form-8-k-financial-statements-5473586)
- 2024-04-24 11:14 UTC [Market Chatter] [First Wave Biopharma Announced Research Generated From Two Previously Completed Phase 2 Clinical Trials Of Latiglutenase Has Been Published In The Special Issue In The Peer-reviewed Scientific Journal](https://www.quantisnow.com/insight/first-wave-biopharma-announced-research-generated-from-two-previously-completed-5428010)
- 2024-04-24 11:00 UTC [First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients](https://www.quantisnow.com/insight/first-wave-biopharma-announces-invited-paper-for-special-edition-on-5427924)
- 2024-04-17 11:00 UTC [Conference Announcement] [First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase](https://www.quantisnow.com/insight/first-wave-biopharma-ceo-james-sapirstein-to-present-at-the-5414408)
- 2024-04-15 11:00 UTC [Conference Announcement] [First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference](https://www.quantisnow.com/insight/first-wave-biopharma-ceo-james-sapirstein-to-participate-in-2024-5409270)
- 2024-04-03 21:14 UTC [SEC Form 4] [Sapirstein James sold $736 worth of shares (174 units at $4.23), decreasing direct ownership by 0.47% to 37,105 units (SEC Form 4)](https://www.quantisnow.com/insight/sapirstein-james-sold-736-worth-of-shares-174-units-at-5389844)
- 2024-04-03 21:13 UTC [SEC Form 4] [Romano Sarah sold $317 worth of shares (75 units at $4.23), decreasing direct ownership by 0.39% to 19,111 units (SEC Form 4)](https://www.quantisnow.com/insight/romano-sarah-sold-317-worth-of-shares-75-units-at-5389825)
- 2024-03-29 20:16 UTC [SEC Form 10-K] [SEC Form 10-K filed by First Wave BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-first-wave-biopharma-inc-5377920)
- 2024-03-25 10:44 UTC [Market Chatter] [HC Wainwright & Co. Reinstates Neutral on First Wave BioPharma](https://www.quantisnow.com/insight/hc-wainwright-co-reinstates-neutral-on-first-wave-biopharma-5364992)
- 2024-03-22 21:00 UTC [SEC Form 8-K] [First Wave BioPharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/first-wave-biopharma-inc-filed-sec-form-8-k-notice-of-5364383)
- 2024-03-19 20:13 UTC [SEC Form 4] [Sapirstein James sold $9,360 worth of shares (1,887 units at $4.96), decreasing direct ownership by 5% to 37,279 units (SEC Form 4)](https://www.quantisnow.com/insight/sapirstein-james-sold-9360-worth-of-shares-1887-units-at-5354673)
- 2024-03-19 20:10 UTC [SEC Form 4] [Romano Sarah sold $5,555 worth of shares (1,120 units at $4.96), decreasing direct ownership by 6% to 19,186 units (SEC Form 4)](https://www.quantisnow.com/insight/romano-sarah-sold-5555-worth-of-shares-1120-units-at-5354634)
- 2024-03-18 20:40 UTC [SEC Form 8-K] [First Wave BioPharma Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/first-wave-biopharma-inc-filed-sec-form-8-k-other-events-5351686)
- 2024-03-18 20:31 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by First Wave BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-first-wave-biopharma-inc-5351585)
- 2024-03-18 11:00 UTC [First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference](https://www.quantisnow.com/insight/first-wave-biopharma-announces-two-abstracts-on-celiac-disease-research-5349660)
- 2024-03-15 22:05 UTC [SEC Form 4] [Syage Jack was granted 15,400 shares (SEC Form 4)](https://www.quantisnow.com/insight/syage-jack-was-granted-15400-shares-sec-form-4-5349099)
- 2024-03-15 22:05 UTC [SEC Form 4] [Khosla Chaitan Phd was granted 440 shares (SEC Form 4)](https://www.quantisnow.com/insight/khosla-chaitan-phd-was-granted-440-shares-sec-form-4-5349098)
- 2024-03-15 22:00 UTC [SEC Form 3] [SEC Form 3 filed by new insider Syage Jack](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-syage-jack-5349094)
- 2024-03-15 22:00 UTC [SEC Form 3] [SEC Form 3 filed by new insider Khosla Chaitan Phd](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-khosla-chaitan-phd-5349093)
- 2024-03-15 13:49 UTC [Market Chatter] [Roth MKM Maintains Buy on First Wave BioPharma, Lowers Price Target to $36](https://www.quantisnow.com/insight/roth-mkm-maintains-buy-on-first-wave-biopharma-lowers-price-5347187)
- 2024-03-15 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-5347063)
- 2024-03-14 17:38 UTC [Market Insight] [Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-limbach-holdings-shares-are-trading-lower-by-around-15-5344435)
- 2024-03-14 17:05 UTC [Market Chatter] [First Wave BioPharma shares are trading lower after the company announced that it completed its merger deal with ImmunogenX.](https://www.quantisnow.com/insight/first-wave-biopharma-shares-are-trading-lower-after-the-company-5344360)
- 2024-03-14 10:10 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by First Wave BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-first-wave-biopharma-inc-5342936)
- 2024-03-14 10:09 UTC [SEC Form 8-K] [First Wave BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/first-wave-biopharma-inc-filed-sec-form-8-k-entry-into-5342930)
- 2024-03-14 10:00 UTC [Market Insight] [First Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Disease](https://www.quantisnow.com/insight/first-wave-biopharma-completes-merger-deal-with-immunogenx-adding-phase-5342853)
- 2024-03-14 10:00 UTC [Earnings Date] [First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline](https://www.quantisnow.com/insight/first-wave-biopharma-announces-completion-of-business-combination-with-immunogenx-5342841)
- 2024-03-05 22:26 UTC [SEC Form 8-K] [First Wave BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/first-wave-biopharma-inc-filed-sec-form-8-k-entry-into-5319217)
- 2024-03-05 12:00 UTC [Conference Announcement] [First Wave BioPharma to Participate In 'Fireside Chat' at the 36th Annual Roth Conference](https://www.quantisnow.com/insight/first-wave-biopharma-to-participate-in-fireside-chat-at-the-5315420)
- 2024-03-04 22:29 UTC [SEC Form 424B5] [SEC Form 424B5 filed by First Wave BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-first-wave-biopharma-inc-5313988)
- 2024-03-04 20:26 UTC [Market Chatter] [First Wave BioPharma shares are trading lower after the company announced a $4 million registered direct offering of 526,625 shares at $7.61 per share.](https://www.quantisnow.com/insight/first-wave-biopharma-shares-are-trading-lower-after-the-company-5312992)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/FWBI
- Earnings history: https://www.quantisnow.com/earnings/FWBI
- Dividend history: https://www.quantisnow.com/dividends/FWBI
- Insider transactions: https://www.quantisnow.com/insiders/FWBI
- Options chain: https://www.quantisnow.com/options/FWBI
- SEC 8-K filings only: https://www.quantisnow.com/company/FWBI/8-k
- RSS and alerts for FWBI: https://www.quantisnow.com/docs/rss-feeds.md
